Clinical Trials
3 trialsNCT02857920 2020-09-14
Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT02843204 2020-05-28
Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid Tumors
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Completed
NCT01611857 2016-11-23
Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach
SCRI Development Innovations, LLC
Phase 1/2 Completed